AGEPHA
Manufacturing · Slovakia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Diaľničná Cesta 5, Bratislava, Bratislav...Phone Number
+44 2032396241Website
www.agephapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About AGEPHA
Agepha Pharma is a family-owned multinational pharmaceutical company dedicated to providing innovative health solutions. They offer a range of products including prescription medicines, over-the-counter remedies, and dietary supplements aimed at enhancing overall well-being. With over 70 years of experience and a commitment to quality, Agepha Pharma serves patients in 47 countries. Their focus is on delivering exceptional care and effective treatments to those in need.Explore more
AGEPHA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AGEPHA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if AGEPHA is spiking on competitors!
Earning: See what the market has to say on AGEPHA recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AGEPHA
Website visits: Recent activity has been detected on your website
AGEPHA, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AGEPHA had a recent Job posting/layoffs
Product Launch: Get notified when AGEPHA launches new products
Funding: Get notified immidiatlly once AGEPHA has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if AGEPHA has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at AGEPHA
Find 3 more new buyers
Company Profile Activity
Activity Insights
AGEPHA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AGEPHA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AGEPHA.
AGEPHA Tech Stack
A closer look at the technologies used by AGEPHA
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Pain Point
Project
A high-level source in Logistics has indicated that the organization is planning to remediate challenges related to artificial intelligence and machine learning. AGEPHA will be increasing investments within the next six months. The organization is researching potential solutions to support remediation efforts.
Pain Point, Spending/Investment, Financial Planning, Machine Learning, Search, Logistics / Supply Chain, Artificial Intelligence
Pain Point
Project
A high-level source in Logistics has indicated that the organization is planning to remediate challenges related to sales and ops planning software. AGEPHA is currently evaluating Salesforce Maps Territory Planning and SAS Demand-Driven Planning and Optimization. The organization will be increasing investments within the next six months.
Pain Point, Spending/Investment, Financial Planning, Sales, Enterprise Software, Software, Workforce Management, Logistics / Supply Chain, Corporate Strategy
Pain Point
Project
A high-level source in Logistics has indicated that the organization is planning to remediate challenges related to demand planning software.
Pain Point, Software, Capacity Planning, Logistics / Supply Chain, Enterprise Resource Planning
Pain Point
Project
Pain Point, Spending/Investment, Financial Planning, Software, Workforce Management, Forecasting, Logistics / Supply Chain, Corporate Strategy
AGEPHA News & Media
Late-Breaking Clinical Trial Presented at the American College of Cardiology Supports Low-Dose Colchicine, 0.5 mg to Treat Cardiovascular Disease by Reducing Progression of Coronary Plaque
PARSIPPANY, N.J.--(BUSINESS WIRE)-- #ACC25--AGEPHA Pharma USA, LLC, is pleased to highlight clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. The study titled, “Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease Compared To Placebo: The Ekstrom Trial,” was presented as a lU.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease
PARSIPPANY, N.J.--(BUSINESS WIRE)-- #ASCVD--AGEPHA Pharma USA, LLC, today announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved LODOCO® as the first anti-inflammatory atheroprotective cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease.1 A
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding AGEPHA
Sign Up For FreeTo access detailed company insights
Agepha Pharma is a family-owned multinational pharmaceutical company dedicated to providing innovative health solutions. They offer a range of products including prescription medicines, over-the-counter remedies, and dietary supplements aimed at enhancing overall well-being. With over 70 years of experience and a commitment to quality, Agepha Pharm... Read More
